Show simple item record

dc.contributor.authorOlivares Hernández, Alejandro
dc.contributor.authorFiguero Pérez, Luis
dc.contributor.authorGonzález Sarmiento, Rogelio
dc.contributor.authorLeón Jiménez, David
dc.contributor.authorCruz Hernández, Juan Jesús
dc.contributor.authorMiramontes González, José Pablo
dc.date.accessioned2023-04-20T07:43:54Z
dc.date.available2023-04-20T07:43:54Z
dc.date.issued2021
dc.identifier.citationApplied Sciences, 2021, vol. 11, n. 18, 8445es
dc.identifier.urihttps://uvadoc.uva.es/handle/10324/59224
dc.descriptionProducción Científicaes
dc.description.abstractCurrently, various immunotherapeutic treatments are revolutionizing therapies that treat solid neoplasms. For these treatments, within immunotherapy, immune checkpoint inhibitors (ICIs) are the most widely used drugs. Diverse studies have shown the influence of diet and probiotics on the response to ICIs and consequently on the survival rates associated with different neoplasms. The use of various antibiotics, probiotics, and prebiotics has been associated with changes in the gut microbiota, and this, in turn, with resistance to immunotherapy. Together with the above, a lower intake of red meat and greater consumption of a Mediterranean, vegetarian, or vegan diet have led to a new way of understanding the mechanisms of resistance to ICIs. Omega-3 and polyphenol supplements are also powerful regulators of the microbiome whose influence on the immune system. Therefore, this review covers the influence of diet and probiotics on the response to immunotherapy in patients who have solid tumours.es
dc.format.mimetypeapplication/pdfes
dc.language.isoenges
dc.publisherMDPIes
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectCancer Researches
dc.subjectImmunologyes
dc.subjectMedicina Internaes
dc.subjectOncologíaes
dc.subject.classificationDietes
dc.subject.classificationProbioticses
dc.subject.classificationImmunotherapyes
dc.subject.classificationSolid tumourses
dc.subject.classificationDietaes
dc.subject.classificationProbióticoses
dc.subject.classificationInmunoterapiaes
dc.subject.classificationTumores sólidoses
dc.titleThe influence of diet and probiotics on the response of solid tumours to immunotherapy: Present and future perspectiveses
dc.typeinfo:eu-repo/semantics/articlees
dc.rights.holder© 2021 The Authorses
dc.identifier.doi10.3390/app11188445es
dc.relation.publisherversionhttps://www.mdpi.com/2076-3417/11/18/8445es
dc.identifier.publicationfirstpage8445es
dc.identifier.publicationissue18es
dc.identifier.publicationtitleApplied Scienceses
dc.identifier.publicationvolume11es
dc.peerreviewedSIes
dc.identifier.essn2076-3417es
dc.rightsAtribución 4.0 Internacional*
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones
dc.subject.unesco3205 Medicina Internaes
dc.subject.unesco3201.01 Oncologíaes


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record